{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:57:43Z","timestamp":1790456263053,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07202-7","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:34:55Z","timestamp":1756395295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictors of extrapyramidal side effects among patients taking antipsychotic medication at Mekelle psychiatry units, Northern Ethiopia, 2023: unmatched case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Welu Abadi","family":"Gebru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebregziabher Kidanemariam","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenfe Tesfay","family":"Berhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye Derbie","family":"Begashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot Gebrewahid","family":"Reta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagos Tsegabrhan","family":"Gebresilassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"5","key":"7202_CR1","first-page":"1","volume":"20","author":"RS Kirgaval","year":"2017","unstructured":"Kirgaval RS, Revanakar S, Srirangapattna C. Prevalence of extrapyramidal side effects in patients on antipsychotics drugs at a tertiary care Center5. J Psychiatry. 2017;20(5):1\u20135.","journal-title":"J Psychiatry"},{"key":"7202_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eurpsy.2017.04.004","volume":"44","author":"R Abboud","year":"2017","unstructured":"Abboud R, Noronha C, Diwadkar VA. Motor system dysfunction in the schizophrenia diathesis: neural systems to neurotransmitters. Eur Psychiatry. 2017;44:125\u201333.","journal-title":"Eur Psychiatry"},{"key":"7202_CR3","doi-asserted-by":"crossref","unstructured":"Girma S, Abdisa E, Fikadu T. Prevalence of antipsychotic drug Non adherence and associated factors among patients with schizophrenia attending at Amanuel mental specialized hospital, addis ababa, ethiopia: institutional based cross sectional study. Health Sci J. 2017;11(4):521.","DOI":"10.21767\/1791-809X.1000520"},{"key":"7202_CR4","doi-asserted-by":"crossref","unstructured":"Tareke M, Tesfaye S, Amare D, Belete T, Abate A. Antipsychotic medication non-adherence among schizophrenia patients in central Ethiopia. South Afr J Psychiatry. 2018;24(1):123\u201330.","DOI":"10.4102\/sajpsychiatry.v24i0.1124"},{"issue":"5","key":"7202_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","volume":"200","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Lewis SW, Barnes TR, Jones PB. Extrapyramidal motor side-effects of first-and second-generation antipsychotic drugs. Br J Psychiatry. 2012;200(5):387\u201392.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"7202_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.euroneuro.2014.11.011","volume":"25","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Ritter M, Malagelada C, Bernardo M, Lafuente A. Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway. Eur Neuropsychopharmacol. 2015;25(1):51\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"7202_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10673220600748486","volume":"14","author":"AA Shirzadi","year":"2006","unstructured":"Shirzadi AA, Ghaemi SN. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harv Rev Psychiatry. 2006;14(3):152\u201364.","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"7202_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/JCP.0000000000000666","volume":"37","author":"TQ Mentzel","year":"2017","unstructured":"Mentzel TQ, Lieverse R, Bloemen O, Viechtbauer W, van Harten PN. High incidence and prevalence of drug-related movement disorders in young patients with psychotic disorders. J Clin Psychopharmacol. 2017;37(2):231\u20138.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"7202_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4088\/JCP.08r04210","volume":"70","author":"JM Kane","year":"2009","unstructured":"Kane JM, Fleischhacker WW, Hansen L, Perlis R, Pikalov IIIA, Assuncao-Talbott S. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiatry. 2009;70(5):627.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"7202_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2165\/00002018-200022010-00006","volume":"22","author":"CH Miller","year":"2000","unstructured":"Miller CH, Fleischhacker WW. Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 2000;22(1):73\u201381.","journal-title":"Drug Saf"},{"issue":"1004","key":"7202_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","volume":"85","author":"B Thanvi","year":"2009","unstructured":"Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009;85(1004):322\u20136.","journal-title":"Postgrad Med J"},{"issue":"4","key":"7202_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.pnpbp.2005.01.014","volume":"29","author":"A Ertugrul","year":"2005","unstructured":"Ertugrul A, Demir B. Clozapine-induced tardive dyskinesia: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(4):633\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"S1","key":"7202_CR13","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/hup.918","volume":"23","author":"PM Haddad","year":"2008","unstructured":"Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacology: Clin Experimental. 2008;23(S1):S15\u201326.","journal-title":"Hum Psychopharmacology: Clin Experimental"},{"issue":"9","key":"7202_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.parkreldis.2009.02.015","volume":"15","author":"CL Go","year":"2009","unstructured":"Go CL, Rosales RL, Caraos RJ, Fernandez HH. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Parkinsonism Relat Disord. 2009;15(9):655\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"7202_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/YIC.0000000000000041","volume":"29","author":"M Ye","year":"2014","unstructured":"Ye M, Tang W, Liu L, Zhang F, Liu J, Chen Y, et al. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. Int Clin Psychopharmacol. 2014;29(6):318\u201321.","journal-title":"Int Clin Psychopharmacol"},{"key":"7202_CR16","doi-asserted-by":"crossref","unstructured":"Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. BioMed research international. 2014;2014.","DOI":"10.1155\/2014\/656370"},{"key":"7202_CR17","doi-asserted-by":"crossref","unstructured":"Weng J, Zhang Y, Li H, Shen Y, Yu W. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia. Gen Psychiatry. 2019;32(1).","DOI":"10.1136\/gpsych-2018-100026"},{"issue":"2","key":"7202_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","volume":"12","author":"AM Kanner","year":"2016","unstructured":"Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nat Reviews Neurol. 2016;12(2):106.","journal-title":"Nat Reviews Neurol"},{"key":"7202_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpsychires.2015.07.015","volume":"69","author":"H Li","year":"2015","unstructured":"Li H, Yao C, Shi J, Yang F, Qi S, Wang L, et al. Comparative study of the efficacy and safety between Blonanserin and Risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial. J Psychiatr Res. 2015;69:102\u20139.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7202_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-013-0222-5","volume":"11","author":"LJ Cloud","year":"2014","unstructured":"Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly common disorder. Neurotherapeutics. 2014;11(1):166\u201376.","journal-title":"Neurotherapeutics"},{"key":"7202_CR21","doi-asserted-by":"crossref","unstructured":"Goldberg JF, Ernst CL. Managing the side effects of psychotropic medications. American Psychiatric Pub; 2018.","DOI":"10.1176\/appi.books.9781615378517"},{"key":"7202_CR22","doi-asserted-by":"crossref","unstructured":"Russo EB, Tyler VM. Handbook of psychotropic herbs: A scientific analysis of herbal remedies for psychiatric conditions. Routledge; 2015.","DOI":"10.4324\/9780203047910"},{"issue":"5","key":"7202_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2174\/1570159X14666161208153644","volume":"15","author":"H Salem","year":"2017","unstructured":"Salem H, Nagpal C, Pigott T, Lucio Teixeira A. Revisiting antipsychotic-induced akathisia: current issues and prospective challenges. Curr Neuropharmacol. 2017;15(5):789\u201398.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"7202_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1517\/14740338.2013.787065","volume":"12","author":"J L\u00f3pez-Send\u00f3n","year":"2013","unstructured":"L\u00f3pez-Send\u00f3n J, Mena MA, de Y\u00e9benes G. Drug-induced parkinsonism. Exp Opin Drug Saf. 2013;12(4):487\u201396.","journal-title":"Exp Opin Drug Saf"},{"issue":"5","key":"7202_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.11648\/j.ajpn.20140205.12","volume":"2","author":"H Taye","year":"2014","unstructured":"Taye H, Awoke T, Ebrahim J. Antipsychotic medication induced movement disorders: the case of Amanuel specialized mental hospital, addis ababa, Ethiopia. Am J Psychiatry Neurosci. 2014;2(5):76\u201382.","journal-title":"Am J Psychiatry Neurosci"},{"issue":"4","key":"7202_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.26502\/jppd.2572-519X0072","volume":"3","author":"T Abdeta","year":"2019","unstructured":"Abdeta T, Tolessa D, Tsega W. Prevalence and associated factors of tardive dyskinesia among psychiatric patients on First-Generation antipsychotics at Jimma university specialized hospital, psychiatric clinic, ethiopia: institution based on A Cross-Sectional study. J Psychiatry Psychiatric Disorders. 2019;3(4):179\u201390.","journal-title":"J Psychiatry Psychiatric Disorders"},{"issue":"1","key":"7202_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12888-018-1999-x","volume":"19","author":"YS Wubeshet","year":"2019","unstructured":"Wubeshet YS, Mohammed OS, Desse TA. Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel mental specialized hospital, central ethiopia: cross-sectional study. BMC Psychiatry. 2019;19(1):32.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"7202_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/wps.20567","volume":"17","author":"TS Stroup","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341\u201356.","journal-title":"World Psychiatry"},{"issue":"3","key":"7202_CR29","first-page":"25","volume":"111","author":"CJ Bachmann","year":"2014","unstructured":"Bachmann CJ, Lempp T, Glaeske G, Hoffmann F. Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012. Deutsches \u00c4rzteblatt International. 2014;111(3):25.","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"7202_CR30","volume-title":"Basic & clinical Pharmacology","author":"C DeBattista","year":"2018","unstructured":"DeBattista C. Basic & clinical Pharmacology. New York: McGraw-Hill; 2018."},{"issue":"6","key":"7202_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/inm.12154","volume":"24","author":"P Morrison","year":"2015","unstructured":"Morrison P, Meehan T, Stomski NJ. A ustralian case managers\u2019 views about the impact of antipsychotic medication on mental health consumers. Int J Ment Health Nurs. 2015;24(6):547\u201353.","journal-title":"Int J Ment Health Nurs"},{"issue":"7","key":"7202_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08039488.2016.1164245","volume":"70","author":"M Parksepp","year":"2016","unstructured":"Parksepp M, Ljubajev \u00dc, T\u00e4ht K, Janno S. Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients. Nord J Psychiatry. 2016;70(7):498\u2013502.","journal-title":"Nord J Psychiatry"},{"key":"7202_CR33","first-page":"23","volume":"455","author":"S Holder","year":"2017","unstructured":"Holder S, Edmunds A, Morgan S. Psychotic and bipolar disorders: antipsychotic drugs. FP Essentials. 2017;455:23\u20139.","journal-title":"FP Essentials"},{"issue":"3","key":"7202_CR34","first-page":"53","volume":"5","author":"G Ayano","year":"2016","unstructured":"Ayano G. First generation antipsychotics: pharmacokinetics, pharmacodynamics, therapeutic effects and side effects: a review. RRJChem. 2016;5(3):53\u201363.","journal-title":"RRJChem"},{"issue":"1","key":"7202_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1192\/bjpo.bp.115.002576","volume":"2","author":"YJ Zhao","year":"2016","unstructured":"Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, et al. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016;2(1):59\u201366.","journal-title":"BJPsych Open"},{"key":"7202_CR36","unstructured":"for Clinical JMEC. First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness. Agency for Healthcare Research and Quality (US); 2013. Comparative Effectiveness Review Summary Guides for Clinicians [Internet]."},{"key":"7202_CR37","doi-asserted-by":"crossref","unstructured":"Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A. Factors associated with medication adherence among patients with schizophrenia in mekelle, Northern Ethiopia. PLoS ONE. 2015;10(3):e0120560.","DOI":"10.1371\/journal.pone.0120560"},{"issue":"5","key":"7202_CR38","first-page":"295","volume":"29","author":"Y Huang","year":"2017","unstructured":"Huang Y, Pan L, Teng F, Wang G, Li C, Jin L. A cross-sectional study on the characteristics of tardive dyskinesia in patients with chronic schizophrenia. Shanghai Archives Psychiatry. 2017;29(5):295.","journal-title":"Shanghai Archives Psychiatry"},{"issue":"8","key":"7202_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40263-015-0269-4","volume":"29","author":"M De Hert","year":"2015","unstructured":"De Hert M, Sermon J, Geerts P, Vansteelandt K, Peuskens J, Detraux J. The use of continuous treatment versus placebo or intermittent treatment strategies in stabilized patients with schizophrenia: a systematic review and meta-analysis of randomized controlled trials with first-and second-generation antipsychotics. CNS Drugs. 2015;29(8):637\u201358.","journal-title":"CNS Drugs"},{"issue":"1\u20133","key":"7202_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.schres.2015.10.040","volume":"169","author":"F Berna","year":"2015","unstructured":"Berna F, Misdrahi D, Boyer L, Aouizerate B, Brunel L, Capdevielle D, et al. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset. Schizophr Res. 2015;169(1\u20133):255\u201361.","journal-title":"Schizophr Res"},{"issue":"4","key":"7202_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/08039488.2013.807875","volume":"68","author":"O Pazvanto\u011flu","year":"2014","unstructured":"Pazvanto\u011flu O, \u015eim\u015fek \u00d6F, Aydemir \u00d6, Sarisoy G, B\u00f6ke \u00d6, \u00dc\u00e7ok A. Factor structure of the subjective Well-being under neuroleptic treatment Scale-short form in schizophrenic outpatients: five factors or only one? Nord J Psychiatry. 2014;68(4):259\u201365.","journal-title":"Nord J Psychiatry"},{"key":"7202_CR42","doi-asserted-by":"crossref","unstructured":"Kassew T, Demilew D, Birhanu A, Wonde M, Liyew B, Shumet S. Attitude towards Antipsychotic Medications in Patients Diagnosed with Schizophrenia: A Cross-Sectional Study at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia. Schizophrenia research and treatment. 2019;2019.","DOI":"10.1155\/2019\/5094017"},{"issue":"3","key":"7202_CR43","first-page":"227","volume":"23","author":"K Tesfay","year":"2013","unstructured":"Tesfay K, Girma E, Negash A, Tesfaye M, Dehning S. Medication non-adherence among adult psychiatric out-patients in Jimma university specialized hospital, Southwest Ethiopia. Ethiop J Health Sci. 2013;23(3):227\u201336.","journal-title":"Ethiop J Health Sci"},{"issue":"7","key":"7202_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0269881109348157","volume":"24","author":"JM Kane","year":"2010","unstructured":"Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, et al. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short-and long-term Aripiprazole trials. J Psychopharmacol. 2010;24(7):1019\u201329.","journal-title":"J Psychopharmacol"},{"key":"7202_CR45","first-page":"1329","volume":"8","author":"Z Demoz","year":"2014","unstructured":"Demoz Z, Legesse B, Teklay G, Demeke B, Eyob T, Shewamene Z, et al. Medication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital. Patient Prefer Adherence. 2014;8:1329.","journal-title":"Patient Prefer Adherence"},{"key":"7202_CR46","doi-asserted-by":"crossref","unstructured":"Endale Gurmu A, Abdela E, Allele B, Cheru E, Amogne B. Rate of nonadherence to antipsychotic medications and factors leading to nonadherence among psychiatric patients in Gondar University Hospital, Northwest Ethiopia. Advances in Psychiatry. 2014;2014.","DOI":"10.1155\/2014\/475812"},{"issue":"1","key":"7202_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-244X-13-168","volume":"13","author":"S Teferra","year":"2013","unstructured":"Teferra S, Hanlon C, Beyero T, Jacobsson L, Shibre T. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry. 2013;13(1):168.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"7202_CR48","first-page":"18","volume":"30","author":"I Bitter","year":"2015","unstructured":"Bitter I, Feh\u00e9r L, T\u00e9nyi T, Czobor P. Treatment adherence and insight in schizophrenia. Psychiatria Hungarica: Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata. 2015;30(1):18\u201326.","journal-title":"Psychiatria Hungarica: Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata"},{"issue":"7","key":"7202_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/14737175.2013.811150","volume":"13","author":"PH Lysaker","year":"2013","unstructured":"Lysaker PH, Vohs J, Hillis JD, Kukla M, Popolo R, Salvatore G, et al. Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Rev Neurother. 2013;13(7):785\u201393.","journal-title":"Expert Rev Neurother"},{"key":"7202_CR50","doi-asserted-by":"crossref","unstructured":"Tariku M, Demilew D, Fanta T, Mekonnen M, Abebaw Angaw D. Insight and Associated Factors among Patients with Schizophrenia in Mental Specialized Hospital, Ethiopia, 2018. Psychiatry Journal. 2019;2019.","DOI":"10.1155\/2019\/2453862"},{"key":"7202_CR51","unstructured":"G\u00f3mez-Arnau. Ram\u00edrez J. Pharmacological and non-pharmacological correlates of acute akathisia in first-episode psychosis. 2016."},{"key":"7202_CR52","unstructured":"PAC A. Basic and clinical pharmacology. 2015."},{"issue":"1","key":"7202_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00716-z","volume":"8","author":"DA Sykes","year":"2017","unstructured":"Sykes DA, Moore H, Stott L, Holliday N, Javitch JA, Lane JR, et al. Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D 2 receptors. Nat Commun. 2017;8(1):1\u201311.","journal-title":"Nat Commun"},{"key":"7202_CR54","first-page":"163","volume-title":"Task force for the handbook of psychiatric measures handbook of psychiatric measures","author":"G Simpson","year":"2000","unstructured":"Simpson G. Simpson-Angus extrapyramidal side effects scale [EPS]. In: Rush AJ Jr, First MB, Blacker D (eds) Task force for the handbook of psychiatric measures handbook of psychiatric measures. Washington, DC: American Psychiatric Association; 2000. pp. 163\u2013164."},{"issue":"2","key":"7202_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1192\/bjp.bp.109.070540","volume":"196","author":"M Poyurovsky","year":"2010","unstructured":"Poyurovsky M. Acute antipsychotic-induced akathisia revisited. Br J Psychiatry. 2010;196(2):89\u201391.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"7202_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00004714-199102000-00005","volume":"11","author":"MG Woerner","year":"1991","unstructured":"Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M et al. The prevalence of tardive dyskinesia. J Clin Psychopharmacol. 1991;11(1):34\u201342.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"7202_CR57","first-page":"32","volume":"22","author":"T Abiola","year":"2013","unstructured":"Abiola T, Udofia O, Zakari M. Psychometric properties of the 3-item Oslo social support scale among clinical students of Bayero university kano, Nigeria. Malaysian J Psychiatry. 2013;22(2):32\u201341.","journal-title":"Malaysian J Psychiatry"},{"issue":"5","key":"7202_CR58","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.2014.7862","volume":"312","author":"R Saitz","year":"2014","unstructured":"Saitz R, Palfai TP, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502\u201313.","journal-title":"JAMA"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07202-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:05:45Z","timestamp":1757498745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07202-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7202"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07202-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3849507\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication, an additional affiliation has been added to Kenfe Tesfay Berhe. The article has been updated to rectify the error.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study were with the ethical standards of the institutional and\/or national research committee and the Helsinki Declaration of 1964. Before the study began ethical clearance was obtained from the Institutional Health Research Ethics Review Committee (IHRERC) of the College of Health and Medical Sciences of Mekelle University with reference number of IHRERC \/1643\/2020. The college sent a letter of cooperation to public hospitals and a written and signed informed consent was obtained from the head of the institutions before starting the data collection. From all of the participants and their parents\/legal guardians informed, voluntary, written, and signed consent was obtained that declare their agreement to participate in the study. For the minor participants informed, voluntary, written, and signed consent was obtained from their parents\/guardian. The information from individual participants was kept confidential, their identity will not be shown and there will be no dissemination of the information without the respondent\u2019s permission. A private room for an interview was prepared; those participants who reported Extrapyramidal Side Effects were immediately linked to the psychiatric outpatient department for further evaluation and management. Interviewers were trained to link participants found to be in physically risky conditions and\/or in immediate need of counseling to psychologists and psychiatrists. During the data collection COVID-19 prevention protocol was taken action like wearing face masks, maintaining physical distance, and using hand sanitizers, which was being practiced by health professionals in the health care setting as a safety measure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"837"}}